Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Structural biology of SARS-CoV-2: open the door for novel therapies

27 Jan 2022

Abstract excerpt

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The discovery of therapy reagents for treating COVID-19 are urgently needed, and the structures of the potential drug-target proteins in the viral life cycle are particularly important. SARS-CoV-2, a member of the Orthocoronavirinae subfamily...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35087058
DOI: 10.1038/s41392-022-00884-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Structural biology of SARS-CoV-2: open the door for novel therapiesPMID 35087058Read ↗

Druggable targets and therapeutic development for COVID-19Semantic proximity Read ↗

Minireview of progress in the structural study of SARS-CoV-2 proteinsSemantic proximity Read ↗

A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sitesSemantic proximity Read ↗

Structural biology of SARS-CoV-2 and implications for therapeutic developmentSemantic proximity Read ↗

An Overview of Basic Molecular Biology of SARS-CoV-2 and Current COVID-19 Prevention Strategies<strong> </strong>Semantic proximity Read ↗

Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach.Semantic proximity Read ↗

Structural and molecular perspectives of SARS-CoV-2Semantic proximity Read ↗

SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine DevelopmentSemantic proximity Read ↗

Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19Semantic proximity Read ↗

An updated review on pathogenic coronaviruses (CoVs) amid the emergence of SARS-CoV-2 variants: A look into the repercussions and possible solutionsSemantic proximity Read ↗

SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic InterventionsSemantic proximity Read ↗

Structural insights into SARS-CoV-2 proteinsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.